Correction of drug dose in patients on hemodiafiltration
Sanz Moreno, C.
Revista Clinica Espanola 198(5): 322-326
1998
ISSN/ISBN: 0014-2565 PMID: 9658916 Document Number: 485771
Document emailed within 1 workday
Related Documents
Colpaert, F.C.; Janssen, P.A. 1982: Factors regulating drug cue sensitivity: the effects of dose ratio and absolute dose level in the case of fentanyl dose-dose discrimination Archives Internationales de Pharmacodynamie et de Therapie 258(2): 283-299Chuchottaworn, C.; Saipan, B.; Kittisup, C.; Cheewakul, K. 2012: Adverse drug reactions and outcome of short course anti-tuberculosis drugs between single daily dose and split drug dose (BID) in pulmonary tuberculosis Journal of the Medical Association of Thailand 95(Suppl 8): S1-S5
Sakharchuk, I.I.; Dudka, P.F.; Il'nitskiĭ, R.I. 1987: Drug correction of blood rheological disorders in patients with chronic cor pulmonale (a review of the literature) Vrachebnoe Delo 1987(7): 4-8
Shilov, V.V.; Batotsyrenov, B.V.; Vasil'ev, S.A.; Shikalova, I.A.; Loladze, A.T. 2011: Correction of nonspecific damages in acute poisoning of substance from the group of opiate drug in patients in critical condition Voenno-Meditsinskii Zhurnal 332(11): 36-39
Vasiliuk, M.D.; Henyk, S.M.; Vasiliuk, I.I. 1993: The indices of the humoral immunity status and its correction in acute drug allergy in patients with the postthrombophlebitic syndrome of the lower extremities Likars'ka Sprava 1993(5-6): 106-110
Pettilä, V.; Tiula, E. 2001: Intermittent hemodiafiltration in acute renal failure in critically ill patients Clinical Nephrology 56(4): 324-331
Elliott, D.; Wiles, C.E.; Reynolds, H.N. 1994: Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration Critical Care Medicine 22(4): 718-9; Author Reply 719-21
Iakovleva, I.I.; Timokoov, V.S.; Lialikova, G.V.; Moroz, V.V. 2005: Insulin-like growth factor 1 in patients with multiple organ dysfunction during hemofiltration/hemodiafiltration Anesteziologiia i Reanimatologiia 2005(2): 72-73
Stringer, J.S.A.; Sinkala, M.; Chapman, V.; Acosta, E.P.; Aldrovandi, G.M.; Mudenda, V.; Stout, J.P.; Goldenberg, R.L.; Kumwenda, R.; Vermund, S.H. 2003: Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine Aids 17(11): 1659-1665
Pasiechnikov, S.P.; Nikulina, G.G.; Kyssa, S.I.; Korol', L.V.; Pietukhova, O.V. 2001: Comparative evaluation of efficiency of transcutaneous laser irradiation of blood and membrane-stabilizing drug therapy in correction of cell metabolism in patients with acute pyelonephritis Likars'ka Sprava 2001(4): 66-70
Raufman, J.P. 1985: Correction: sulfasalazine dose Annals of Internal Medicine 102(1): 139
Evens, R.P.; Yanchick, V. 1984: Unit-dose systems: drug waste and drug processing time in a long-term care facility Hospital Formulary 19(6): 454-458
Kornchankul, W.; Hamed, E.; Parikh, N.H.; Sakr, A. 2002: Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer Die Pharmazie 57(1): 49-53
2011: Low-dose combination of perindopril arginine with indapamide in correction of metabolic syndrome Terapevticheskii arkhiv 83(10): 40-45
Cardozo, L.; Lisec, M.; Milard, R.; Van Vierssen Trip, O.; Kuzmin, I.; Drogendijk, T.E.; Huang, A.M. 2007: A placebo-controlled, double-blind, randomized trial of single daily dose of anti-muscarinic drug solifenacin succinate in patients with overactive bladder Akusherstvo i Ginekologiia 46(5): 55-57
Scholten, S.L. 1991: Correction to AHFS Drug Information 91 American Journal of Hospital Pharmacy 48(12): 2606
Davis, J.C.; Fessler, B.J.; Tassiulas, I.O.; McInnes, I.B.; Yarboro, C.H.; Pillemer, S.; Wilder, R.; Fleisher, T.A.; Klippel, J.H.; Boumpas, D.T. 1998: High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis Journal of Rheumatology 25(9): 1694-1704
Clark, M.L.; Costiloe, J.P.; Wood, F.; Paredes, A.; Fulkerson, F.G. 1977: Butaclamol in newly admitted chronic schizophrenic patients: a modified fixed-dose dose-range design Diseases of the Nervous System 38(11): 943-947
Dück, K.D. 1980: Development and drug correction of therapy resistance in chronic antihypertensive use Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 35(20): Supply 123-5
Somova, M.N.; Muzalevskaia, E.N.; Nikolaevskiĭ, V.A.; Buzlama, A.V.; Batishcheva, G.A.; Chernov, I.N. 2013: Drug-induced liver damage and the problem of its pharmacological correction Eksperimental'naia i Klinicheskaia Farmakologiia 76(9): 38-43